These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27757024)

  • 1. Type 2 diabetes: cost-effectiveness of medication adherence and lifestyle interventions.
    Nerat T; Locatelli I; Kos M
    Patient Prefer Adherence; 2016; 10():2039-2049. PubMed ID: 27757024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
    Eddy DM; Schlessinger L; Kahn R
    Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis of the implementation of guidelines for type 2 diabetes control developed by Diabetes Poland: what increase in costs is justified by clinical results?
    Szmurło D; Schubert A; Kostrzewska K; Ryś P; Skrzekowska-Baran I
    Pol Arch Med Wewn; 2011 Oct; 121(10):345-50. PubMed ID: 22045095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland.
    Hiligsmann M; McGowan B; Bennett K; Barry M; Reginster JY
    Value Health; 2012; 15(5):604-12. PubMed ID: 22867768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial.
    Duijzer G; Bukman AJ; Meints-Groenveld A; Haveman-Nies A; Jansen SC; Heinrich J; Hiddink GJ; Feskens EJM; de Wit GA
    BMC Health Serv Res; 2019 Nov; 19(1):824. PubMed ID: 31711499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness Analysis of Knee Osteoarthritis Treatment.
    Stan G; Orban H; Orban C
    Chirurgia (Bucur); 2015; 110(4):368-74. PubMed ID: 26305202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
    Diabetes Prevention Program Research Group
    Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.
    Ackermann RT; Marrero DG; Hicks KA; Hoerger TJ; Sorensen S; Zhang P; Engelgau MM; Ratner RE; Herman WH
    Diabetes Care; 2006 Jun; 29(6):1237-41. PubMed ID: 16732002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective.
    Anderson JM
    J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.
    Neumann A; Lindholm L; Norberg M; Schoffer O; Klug SJ; Norström F
    Eur J Health Econ; 2017 Sep; 18(7):905-919. PubMed ID: 27913943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia.
    Malkin SJP; Russel-Szymczyk M; Liidemann G; Volke V; Hunt B
    Diabetes Ther; 2019 Feb; 10(1):159-176. PubMed ID: 30535837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
    Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications.
    Chapman RH; Kowal SL; Cherry SB; Ferrufino CP; Roberts CS; Chen L
    Value Health; 2010; 13(6):685-94. PubMed ID: 20825627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma.
    Hung A; Williams AM; Newman-Casey PA; Muir KW; Gatwood J
    Ophthalmol Glaucoma; 2023; 6(4):395-404. PubMed ID: 36707031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
    Tunis SL; Willis WD; Foos V
    Curr Med Res Opin; 2010 Jan; 26(1):163-75. PubMed ID: 19919377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.